Polyps are abnormal development of tissues projecting from a mucous membrane, normally originating in the uterus, urinary bladder, sinus, ear, nose, stomach, or colon. However, these can form in other places in the body where mucous membranes are present. Most polyps are non-cancerous or benign; however, some are premalignant. Premalignant polyps is one of the factor which can trigger the cancer development. Generally, the risk of cancer is related to the size of polyps, larger the polyps, higher the risk of cancer, particularly with premalignant polyps. Diagnosis of polyps is difficult and screening is the only reliable measure to detect it. Symptoms related to polyps are vomiting, nausea, constipation, diarrhea, pain, dysmenorrhea, vaginal bleeding, and irregular periods in women.
Cause of polyps can vary based on location. For instance, polyps of the throat are a result of an injury from shouting loudly or damage from a breathing tube. In some cases, physicians cannot determine the actual cause of polyps. Some known causes of polyps are excess estrogen, chronic stomach inflammation, mutation in the genes of colon cells, tumor, cyst, foreign object, and inflammation.
Polyps develop by quickly dividing cells, which is similar to growth of cancer cells. Hence, these can turn cancerous although most polyps are benign in nature. Polyps are major risk factors of colon cancer and colorectal cancer initiates as polyps, a growth in the inside lining of the rectum or colon. Adenoma, a certain kind of polyp that has greater risk of developing into colorectal cancer, is the third most common type of non-skin cancer in both men and women. It is the second major cause of cancer deaths in the U.S. after lung cancer. According to the U.S. Department of Health and Human Services, around 134,490 people in the U.S. were diagnosed with colorectal cancer in 2016 and around 49,190 people succumbed due to the disease.
Rise in awareness about polyps and its potentially cancerous nature and increase in screening are the major factors boosting the growth of the global polyps market. Increase in geriatric population is another major factor driving the global market. However, several risks associated with polyps such as blood loss and infection during surgery, personal or family history of polyps, and no symptoms are the major restraints of the global market. High cost of nominally invasive surgeries and less health care spending in developing regions are the other factors restraining the global polyps market.
The global polyps market can be segmented based on type of polyps, diagnosis, treatment, end-user, and region. In terms of type of polyps, the global market can be classified into premalignant, laryngeal, nasal, cervical, endometrial, and digestive. Based on diagnosis, the global polyps market can be categorized into computed tomography, double contrast barium enema, sigmoidoscopy, colonoscopy, stool and occult blood test, and others. In terms of treatment, the global market can be bifurcated into drugs and surgery. Drugs can be divided into painkillers, hormonal drugs, and others. Based on end-user, the global polyps market can be classified into hospitals & clinics, academic & research institutes, and others.
In terms of region, the global polyps market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. North America is expected to dominate the global polyps market due to availability of advanced drug formulations. Awareness among people about polyps is also a major factor boosting the market in the region. The polyps market in Asia Pacific is anticipated to expand at a rapid pace due to increase in geriatric population. Lack of awareness about polyps and unavailability of advanced medication and surgical procedures in underdeveloped countries such as Lebanon, Syria, Cyprus, Turkey, and Iraq are likely to restrain the growth of the polyps market in Middle East & Africa.
Top players operating in the global polyps market are Novartis AG, Teva Pharmaceutical Industries Ltd., and Pfizer Inc., among others.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.